| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 45,551 | 39,708 | 37,893 | | Cost of Revenue | 20,091 | 22,066 | 19,587 | | | Gross Profit | 25,460 | 17,642 | 18,307 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 11,852 | 12,125 | 12,380 | | Non Recurring |
-
|
-
|
-
| | Others | 260 | 90 | 90 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 13,348 | 5,427 | 5,837 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| | Earnings Before Interest And Taxes | 13,348 | 5,427 | 5,837 | | Interest Expense | 5,847 | 2,419 | 2,014 | | Income Before Tax | 7,501 | 3,008 | 3,823 | | Income Tax Expense | 2,364 | 636 | 1,351 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 5,136 | 2,372 | 2,472 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 5,136 | 2,372 | 2,472 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,136 | $2,372 | $2,472 |
|
0.22% Nasdaq 
Income Statement
